Home >Current Issue

Volume: 9, Issue: 2, February, 2019
DOI: 10.7324/JAPS.2019.90202

Research Article

Synthesis and anticonvulsant activity of 6-methyl-2-thioxo-2, 3-dihydropyrimidin-4(1H)-one acetamides

Hanna Severina1, Olha Skupa2, Andrei Khairulin3, Natalya Voloshchuk2, Victoria Georgiyants1

  Author Affiliations


This research aimed at synthesizing new potential anticonvulsants in the series of 2-(4-methyl-6-oxo-1,6-dihydropyrimidin2-yl)thio-acetamides. An initial intermediate 6-methyl-2-thioxo-2,3-dihydro-pyrimidin-4(1Н)-one was obtained by the reaction of thiourea with an acetoacetic ester in the presence of sodium methoxide. The target 2-(4-methyl-6-oxo-1,6- dihydropyrimidin-2-yl) thioacetamides were synthesized by alkylation of initial 6-methyl-2-thiopyrimidin-4-one with corresponding 2-chloroacetamides in Dimethylformamide (DMF) in the presence of potassium carbonate. The structure of compounds was confirmed by 1 H Nuclear magnetic resonance (NMR)-spectroscopy, LCMS, and elemental analysis. A screening of anticonvulsant activity of synthesized compounds was carried out using the pentylenetetrazole- and maximal electroshock-induced seizures models. In these studies, the highest anticonvulsant activity demonstrated a compound 5.5 2-[(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)thio]-N-(4-bromophenyl)-acetamide, which decreased the lethality, the number and the severity of seizures, and increased their latent period. For these compound parameters of ЕD50, acute (LD50) and neurotoxicity (TD50), as well as therapeutic (TI) and protective (PI) indexes were determined. Logical structure analysis of anticonvulsant activity screening revealed some patterns of “structure–activity” relationship.


2-thiopyrimidine, alkylation, acetamides, anticonvulsant activity.

Citation: Severina H, Skupa O, Khairulin A, Voloshchuk N, Georgiyants V. Synthesis and anticonvulsant activity of 6-methyl-2- thioxo-2,3-dihydropyrimidin-4(1H)-one acetamides. J Appl Pharm Sci, 2019; 9(02):012–019.

Copyright: The Author(s). This is an open access article distributed under the Creative Commons Attribution Non-Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Azizi F, Malboosbaf R, Antithyroid Drug Treatment: a Systematic Review and Meta-Analysis. Thyroid. 2017; 27: 1223-1231. https://doi.org/10.1089/thy.2016.0652

Basavaraja HS, Jayadevaiah KV, Mumtaz MH, Vijay Kumar MM. Synthesis of novel piperazine and morpholine linked substituted pyrimidine derivatives as antimicrobial agents. J Pharm Sci Res. 2010; 2: 5-12. http://www.pharmaexpert.ru/passonline/

Cooper DS. Antithyroid drugs. N Engl J Med. 2005; 352: 905-917. https://doi.org/10.1056/NEJMra042972

Crepaldi P, Cacciari B, Bonache MC, Spalluto G, Varani K, Borea PA, Kügelgen IV, Hoffmann K, Pugliano M, Razzar C, Cattaneo M. 6-Amino-2-mercapto-3H-pyrimidin-4-one derivatives as new candidates for the antagonism at the P2Y12 receptors. Bioorg Med Chem. 2009; 17: 4612-4621. https://doi.org/10.1016/j.bmc.2009.04.061

Danel К,Pedersen EB, Nielsen C. Synthesis and Anti-HIV-1 Activity of Novel 2,3-Dihydro-7H-thiazolo[3,2-a]pyrimidin-7-ones. J Med Chem. 1998;41: 191–198. https://doi.org/10.1021/jm970443m

Fisher RS. Animal models of the epilepsies. Brain Research Reviews. 1989; 14: 245–278. https://doi.org/10.1016/0165-0173(89)90003-9

Gagnon A, Amad AH, Pierre R, Bonneau PR, Coulombe R, DeRoy PL, Doyon L, Duan J, Garneau M, Guse I, Jakalian A, Jolicoeur E, Landry S. Thiotetrazolealkynylacetanilides as potent and bioavailable non-nucleoside inhibitors of the HIV-1 wild type and K103N/Y181C double mutant reverse transcriptases. Bioorg Med Chem Lett. 2007;17: 4437–4441. https://doi.org/10.1016/j.bmcl.2007.06.012

Gerald MC, Riffee WH. Acute and chronic effects of d- and 1-amphetamine on seizure susceptibility in mice.Eur J Pharmacol. 1973; 21: 323-330. https://doi.org/10.1016/0014-2999(73)90134-9

Gorneva G, Mateva R, Gugova R, Golovinsky E. The study of the apoptogenic effect of pyrimidine derivatives on murine leukemia cells. Arch Oncol. 2005; 13: 62-64. https://doi.org/10.2298/AOO0502062G

Levine JA, Ferrendelli JA, Covey DF. Alkyl-substituted thiolo-, thiono-, and dithio-γ-buthyrolactones: new classes of convulsant and anticonvulsant agents. J Med Chem. 1986; 29: 1996-1999. https://doi.org/10.1021/jm00160a032

Loscher W, Fiedler M. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. VI. Seasonal influences on maximal electroshock and pentylenetetrazole seizure thresholds. Epilepsy Research. 1996; 25: 3–10. https://doi.org/10.1016/0920-1211(96)00022-8

Löscher W, Hönack D, Fassbender CP, Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Research. 1991;8: 171–189. https://doi.org/10.1016/0920-1211(91)90062-K

Löscher W. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs. Seizure. 2011; 20: 359-368. https://doi.org/10.1016/j.seizure.2011.01.003

Mai A, Sbardella G, Artico M, Ragno R, Massa S, Novellino E, Greco G, Lavecchia A, Musiu C, La Colla M, Murgioni C, La Colla P, Loddo R. Structure-Based Design, Synthesis, and Biological Evaluation of Conformationally Restricted Novel 2-Alkylthio-6-[1-(2,6-difluorophenyl)alkyl]- 3,4-dihydro-5-alkylpyrimidin-4(3H)-ones as Non-nucleoside Inhibitors of HIV-1 Reverse Transcriptase. J Med Chem. 2001; 44: 2544–2554. https://doi.org/10.1021/jm010853h

Matias M, Campos G, Silvestre S, Falcão A, Alves G. Early preclinical evaluation of dihydropyrimidin(thi)ones as potential anticonvulsant drug candidates.Eur J Pharm Sci. 2017;102: 264–274. https://doi.org/10.1016/j.ejps.2017.03.014

Metcalf CS, WestPJ, Thomson K, Edwards S, SmithMD,WhiteHS, WilcoxKS. Development and Pharmacological Characterization of the Rat 6 Hz Model of Partial Seizures. Epilepsia. 2017; 58: 1073–1084. https://doi.org/10.1111/epi.13764

Nawrozkij MB, Rotili D, Tarantino D, Botta G, Eremiychuk AS, Musmuca I, Ragno R, Samuele A, Zanoli S, Armand-Ugón M, Clotet-Codina I, Novakov IA Orlinson BS, Maga G, Esté JA, Marino Artico M, Antonello Mai A. 5-Alkyl-6-benzyl-2-(2-oxo-2-phenylethylsulfanyl)pyrimidin-4(3H)-ones, a Series of Anti-HIV-1 Agents of the Dihydro-alkoxy-benzyl-oxopyrimidine Family with Peculiar Structure−Activity Relationship Profile. J Med Chem. 2008; 51: 4641–4652. https://doi.org/10.1021/jm800340w

Novikov MS, Ozerov AA, Sim OG. Synthesis of 5-[2-(phenoxy)ethyl] derivatives of 6-methyluracil, 6-methyl-2-thioxo-2,3-dihydro-1H-pyrimidin-4-one and 2-imino-6-methyl-2,3-dihydro-1H-pyrimidin-4-one. ChemHeterocycl Compd. 2005; 8: 1036-1040. https://doi.org/10.1007/s10593-005-0275-4

Prozorovsky VB. Statistic processing of data of pharmacological investigations. Psychopharmacology and biological narcology. 2007; 7: 2090-2120.

Rakhimov AI, Titova ES. Synthesis of 2-alkyl(aralkyl)Sulfanyl-6-methylpyrimidin-4(3H)-ones and 4-alkyl(aralkyl)oxy-2-alkyl (aralkyl)sulfanyl-6-methylpyrimidines. Russ. J Org Chem. 2007;43: 92-98. https://doi.org/10.1134/S1070428007010125

Russo H, Bressolle F. Pharmacodynamic and Pharmacokinetic of Thiopental. ClinPharmakokinet. 1998;35: 95-134. https://doi.org/10.2165/00003088-199835020-00002

SaidovNB,Kadamov IM,Georgiyants VA,TaranAV. Planning, Synthesis, andPharmacologicalActivityofAlkylDerivativesof 3-Mercapto-4-Phenyl-5-Arylaminomethyl-1,2,4-Triazole-(4H). Pharm Chem J. 2014; 47: 581-585. https://doi.org/10.1007/s11094-014-1011-0

Severina AI, Skupa OO, Georgiyants VA, Voloshchuk NI Screening of anticonvulsant activity of new pyrimidin-4(3H)-one derivatives [ONLINE] Med educ in Siberia. 2013. Available at: (http://www.ngmu.ru/cozo/mos/article/text_full.php?id=1034).

Shigeta S, Mori S, Kira T, Takahashi K, Kodama E, Konno K, Nagata T, Kato H, Wakayama T, Koike N, Saneyoshi M. Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro. AntivirChemChemother. 2003; 10: 195–209. https://doi.org/10.1177/095632029901000404

Article Metrics

Similar Articles